[Clinical study of multiple myeloma: a report of 182 cases].
Lists
Only you see this
Abstract
ISS is more applicable than DS, especially for low risk patients. The efficacy of VAD-like regimen combined Thal as first-line treatment is proven to be reliable. Induction therapy including thalidomide can not only improve the ORR, but also delay the relapse or progression of disease. It may even prolong the patient survival.
BibTeX
@inproceedings{xu2010clinical,
author = {Lan Xu and Yan Wang and Wen‐Chi Wu and Hua Yan and Xiao‐Dong Gao and Qing Yu and Zhixiang Shen and Jian‐Qing Mi},
title = {{[Clinical study of multiple myeloma: a report of 182 cases].}},
booktitle = {PubMed},
year = {2010},
}Loading related content...